Metacam Meloxicam 0.5 Mg/Ml Oral Suspension Dogs

12 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

1670.0%

Death Rate

Active Ingredients

Metacam Meloxicam 0.5 Mg/Ml Oral Suspension Dogs

Administration Routes

Oral

Species Affected

Dog 8

Cat 2

Pig 1

Parrot 1

Most Affected Breeds

Domestic Shorthair 2

Shih Tzu 2

Spaniel - King Charles Cavalier 1

Terrier - Yorkshire 1

Vietnamese Pot Bellied 1

Poodle - Miniature 1

Terrier (unspecified) 1

Retriever - Golden 1

Spitz - German Pomeranian 1

Parrot (other) 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in Neurological) 2

Not eating 2

Death 2

Injection site serous discharge 1

Cutaneous necrosis 1

Injection site pain 1

Injection site scab 1

Nausea 1

Biting - pruritus (see also Behavioural disorders) 1

Injection site alopecia 1

Hyperpigmentation 1

Drooling 1

Outcome Breakdown

Recovered/Normal

6 (50.0%)

Outcome Unknown

4 (33.3%)

Died

2 (16.7%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.